Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chrystal Ann Landry
Observed names:
C Landry,
Chrystal A. Landry,
Chrystal Landry
Institution:
Memorial Sloan Kettering Cancer Center
Observed institutions:
Northwell Health,
Memorial Sloan Kettering Cancer Center,
NewYork–Presbyterian Hospital,
Hofstra University,
Cornell University,
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell,
Weill Cornell Medicine,
Icahn School of Medicine at Mount Sinai
show all 8
ORCID:
0000-0002-2852-2818
Observed ORCID:
0000-0002-2852-2818
OpenAlex ID:
A5031347993
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
2016
·
H Landau
, M Smith
, et al.
·
Leukemia
·
56
PDF
Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer
2020
·
Andrea M. Tufano
, Eleonora Teplinsky
, et al.
·
Clinical Breast Cancer
·
22
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
2023
·
Chrystal A. Landry
, Julia Blanter
, et al.
·
Oncology
·
3
A phase Ib study evaluating the safety and tolerability of durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer.
2018
·
Chrystal Ann Landry
, Jeannette Marcelle Guziel
, et al.
·
Journal of Clinical Oncology
·
3
Multiple Copies of MLL Is The Most Commonly Detected Cytogenetic Abnormality In Newly Diagnosed Multiple Myeloma and May Modify Disease Risk
2013
·
Chrystal Landry
, Dory Londono
, et al.
·
Blood
·
3
Topical Calcineurin Inhibitors
2014
·
Mark G. Lebwohl
, Chrystal A. Landry
·
CRC Press eBooks
·
2
Abstract PO4-19-11: A Multicenter, Phase Ib/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
2024
·
Nicole Casasanta
, Chrystal Landry
, et al.
·
Cancer Research
·
1
Multiple copies of MLL as a commonly detected cytogenetic abnormality in newly diagnosed symptomatic multiple myeloma.
2014
·
Chrystal Ann Landry
, Dory Londono
, et al.
·
Journal of Clinical Oncology
·
1
Is inpatient chemotherapy overutilized?
2020
·
Natalie S Berger
, Giulia Petrone
, et al.
·
Journal of Clinical Oncology
Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with metastatic HER2-negative breast cancer and recurrent ovarian cancer.
2020
·
Chrystal Ann Landry
, Meng Ru
, et al.
·
Journal of Clinical Oncology
Improving communication about prognosis on an academic inpatient solid tumor oncology consult service.
2018
·
Chrystal Ann Landry
, Alaina J Kessler
, et al.
·
Journal of Clinical Oncology
Standardizing documentation and improving communication on an academic inpatient solid tumor oncology consult service.
2018
·
Chrystal Ann Landry
, Alaina J Kessler
, et al.
·
Journal of Clinical Oncology
Clinical characteristics, demographics, and outcomes in hormone-receptor (HR+) positive metastatic breast cancer (MBC) patients treated with palbociclib.
2018
·
Chrystal Ann Landry
, Maya Dimitrova
, et al.
·
Journal of Clinical Oncology
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
2015
·
Gunjan L. Shah
, Chrystal Landry
, et al.
·
Transplantation and Cellular Therapy
Increased Bone Marrow Plasma Cells at Diagnosis Predicts Overall Mortality in AL Amyloidosis Patients Undergoing Risk-Adapted Stem Cell Transplant
2014
·
Chrystal A. Landry
, Melody Smith
, et al.
·
Blood
Show more works
View as search
Works count:
15
Citation count:
91
H-index:
3
I10-index:
2
Year
Topic
Type
